• Info
  • Insider Trading

Insider Transactions Reported by 15 Insiders of Checkmate Pharmaceuticals, Inc.

Location
Cambridge, MA

There are no Buy or Sell transactions made by insiders since 11 Mar 2025

Checkmate Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Novo Holdings A/S 10%+ Owner $22,592,579 23 Feb 2022
venBio Global Strategic Fund II L.P. 10%+ Owner $22,529,253 13 May 2022
Arthur M. Krieg Chief Scientific Officer $8,524,339 18 Jun 2021
Flaherty Keith T. Director 31 May 2022
Peter Colabuono Director 31 May 2022
Oren Isacoff Director 31 May 2022
Kleem Chaudhary Chief Business Officer 04 Aug 2021
James Wooldridge Chief Medical Officer 31 May 2022
Robert Dolski Chief Financial Officer 31 May 2022
Joy Yan Director 31 May 2022
ALAN BASH Chief Executive Officer, Director 31 May 2022
MICHAEL POWELL Director 31 May 2022
Barry Labinger President and CEO, Director 04 Aug 2021
Alan Fuhrman Director 31 May 2022
Jon Marc Wigginton Director 31 May 2022

Recent Insider Transactions by Companies or Individuals for Checkmate Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.